Fulvestrant (ICI-182780)

Catalog No.S1191 Synonyms: ZD 9238, ZM 182780

For research use only.

Fulvestrant (ICI-182780, ZD 9238, ZM 182780) is an estrogen receptor (ER) antagonist with IC50 of 0.94 nM in a cell-free assay. Fulvestrant also induces autophagy and apoptosis and has antitumor activity.

Fulvestrant (ICI-182780) Chemical Structure

CAS No. 129453-61-8

Selleck's Fulvestrant (ICI-182780) has been cited by 109 publications

Purity & Quality Control

Choose Selective Estrogen/progestogen Receptor Inhibitors

Other Estrogen/progestogen Receptor Products

Biological Activity

Description Fulvestrant (ICI-182780, ZD 9238, ZM 182780) is an estrogen receptor (ER) antagonist with IC50 of 0.94 nM in a cell-free assay. Fulvestrant also induces autophagy and apoptosis and has antitumor activity.
Targets
ER [1]
(Cell-free assay)
0.94 nM
In vitro

Fulvestrant is an effective inhibitor of the growth of ER-positive MCF-7 (with IC50 of 0.29 nM) but with no effect on the growth of ER-negative BT-20 human breast cancer cells. Fulvestrant causes accumulation of cells in G0/G1 and also reduces the proportion of cells capable of continued DNA synthesis. [1] Fulvestrant competitively inhibits binding of oestradiol to the estrogen receptor. Fulvestrant blocks nuclear localization of the ER through impairing receptor dimerisation, and energy-dependent nucleo-cytoplasmic shuttling. Because of the instability of fulvestrant-ER complex, the binding of Fulvestrant with ER finally results in accelerated degradation of the ER protein. [2] Fulvestrant (10 nM) not only decreases IGF-IR mRNA levels but also decreases the half-life. [3] Treatment with 100 μM Fulvestrant leads to a time dependent increase of TNFR1 and TRADD steady-state mRNA levels in MCF-7 cells. [4] Fulvestrant is capable of down-regulating androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells. Fulvestrant also significantly attenuates R1881-stimulated growth by 70%. [5] Fulvestrant is able to modulate mitosis and cell death in immature cerebellar neurons via rapid activation of MAPK. [6]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MCF-7 NX3md21wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVTDPZlXOS5|LUGwNFAhdk1? NEXYW3M1QCCq NUjSRW1{cW6qaXLpeJMh[2WubDDndo94fGhiaX6gZUBld3OnLXTldIVv\GWwdDDtZY5v\XJ? Ml3PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7N{myPVQoRjJ2OUe5Nlk1RC:jPh?=
MCF-7/LTED Ml3pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13rOFEvOy1zMECwJI5O MUO0PEBp MYTpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=> MoDsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7N{myPVQoRjJ2OUe5Nlk1RC:jPh?=
HCC1428 NYnDRm95T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX3jTJhUOS5|LUGwNFAhdk1? MUi0PEBp MlPjbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> M1zCSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUe5Nlk1Lz5{NEm3PVI6PDxxYU6=
HCC1428/LTED MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVOxMlMuOTByMDDuUS=> MXW0PEBp M4HTXIlvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz NX[3U3pxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5O|kzQTRpPkK0PVc6Ojl2PD;hQi=>
LCC1 NWrDRZk4TnWwY4Tpc44hSXO|YYm= MVKxNFAhdk1? M1fJU|Q5NTF2NDDo NYOzNmRr[WO2aY\heIV{KFWSUjDzbYdv[Wyrbne= NXnQTXFURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVgzPzdpPkK0PFU5Ojd5PD;hQi=>
LCC9 NE\SfmhHfW6ldHnvckBCe3OjeR?= MV[xNFAhdk1? MUK0PE0yPDRiaB?= MYHhZ5RqfmG2ZYOgWXBTKHOrZ37hcIlv\w>? M1nWZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEW4Nlc4Lz5{NEi1PFI4PzxxYU6=
MCF-7  NWr4XFRZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIfWN2cyODBibl2= NE\Wd4g2KGR? M4[0XYlvcGmkaYTzJINmdGxiZ4Lve5RpKHSxIEGw89yG MojOQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6MUm1OVAoRjJ2OEG5OVUxRC:jPh?=
mesangial  NYH6TGhHTnWwY4Tpc44hSXO|YYm= MXewMlEuOTByIH7N NIjNOXA1QCCq NE\EXoR{fXCycnXzd4V{KFSJRj5OtlEucW6mdXPl[EB1gXCnIFnWJINwdGyjZ3Xu Mn3ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5OUO2N|koRjJ2N{mzOlM6RC:jPh?=
Mesangial M1WxWWZ2dmO2aX;uJGF{e2G7 M2\DS|AvOS1zMECgcm0> NXPFcpRHOC53IHi= MULpcohq[mm2czDUS2Yu|rJzLXnu[JVk\WRiU33h[FIheGixc4Doc5J6dGG2aX;uJJZq[SCJUFXS MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd7M{[zPUc,OjR5OUO2N|k9N2F-
ER+ MCF-7/2a MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWTJR|UxRTBwMEC0JO69VQ>? NIfqd5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUOyOFg5PCd-MUWzNlQ5QDR:L3G+
ER+ MCF-7 NViyflEzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3;OO|IxOCCq NGDhTpRKSzVyPUCuNlEhdk1? NVXzZ41ZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUWzNlQ5QDRpPkG1N|I1QDh2PD;hQi=>
MCF-7  NUjrOoRzTnWwY4Tpc44hSXO|YYm= NXLTU3BpOTEEoH7NxsA> MYe3NkBp MkPkdoV3\XK|ZYOgeIhmKGW|dILv[4VvKGWoZnXjeEhKSzVyIEGuPUDEnyBzMPMIllkhVSl? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyOE[1Nkc,OjR7MEi2OVI9N2F-
MCF-7  Mn7US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYjJR|UxyqCxZjDhdJBzd3irbXH0[Yx6KDJibl2= M17xfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NES4N|Q3Lz5{M{S0PFM1PjxxYU6=
H1975  MlrjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2T5RlPDqM7:TR?= M3HwRVEhdQ>? NHjyfZFqdmO{ZXHz[ZMhfGinIHfl[ol1cW6rYjDz[Y5{cXSrdnn0fUBw\iCKMUm3OUBk\Wyuc9Mg M3zocFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2Mk[4PFExLz5{NEK2PFgyODxxYU6=
H1975 M1fMOWZ2dmO2aX;uJGF{e2G7 MUOzxsDPxE1? Mkf3NUBu NVniRVk5fXC{ZXf1cIF1\XNidHjlJIxmfmWuIH;mJGxmfC15Yx?= MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDJ4OEixNEc,OjR{Nki4NVA9N2F-
MCF-7  NF[wVWpHfW6ldHnvckBCe3OjeR?= M2XtVFExOOLCiX7NxsA> NYXYTnpxPzJiaB?= NXO1bVRCemW4ZYLz[ZMhfGinIIDyc5Rm[3SrdnWg[YZn\WO2IH;mJGUzyqCrbjDj[YxtKGmwdnHzbY9v NH7PS5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mzOlc4Oyd-MkO5N|Y4PzN:L3G+
MCF-7  NVK0VoZ[TnWwY4Tpc44hSXO|YYm= M3vGfFExOOLCiX7NxsA> MmHyNlQwPDhiaB?= NFvUco9n[WOrbHn0ZZRmeyCrbo\hd4lwdiC2aILveYdpKE2PUIOnJI1w\HWuYYTpc44> MmTyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN7M{[3O|MoRjJ|OUO2O|c{RC:jPh?=
BT474-tet-shMED1 M3\mTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4Xo[VAvOS13IN88US=> MUO3JIQ> M1TJdolv[3KnYYPld{AsTG:6IHnu[JVk\WRiY3XscEBl\WG2aDDpckBiKGSxc3Wt[IVx\W6mZX70JI1idm6nch?= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzl|NkKzOEc,OjN7M{[yN|Q9N2F-
ZR75-1-tet-shMED1  MnrNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXW3PHJROC5zLUWg{txO MX:3JIQ> Ml2wbY5kemWjc3XzJEtFd3hiaX7keYNm\CClZXzsJIRm[XSqIHnuJIEh\G:|ZT3k[ZBmdmSnboSgcYFvdmW{ NInKPWU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mzOlI{PCd-MkO5N|YzOzR:L3G+
MCF-7-tet-shMED1 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXqXG8xNjFvNTFOwG0> NYDVR2RRPyCm M3\HV4lv[3KnYYPld{AsTG:6IHnu[JVk\WRiY3XscEBl\WG2aDDpckBiKGSxc3Wt[IVx\W6mZX70JI1idm6nch?= NFLTOWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mzOlI{PCd-MkO5N|YzOzR:L3G+
HepG2  M4LEZWZ2dmO2aX;uJGF{e2G7 NX;nUWdqOC5yMT2xNEDPxE1? MUexPEBpyqB? MmXVZYN1cX[jdHXzJJRp\SCHUlWtcYVlcWG2ZXSgeJJidnOlcnnweIlwdiCxZjDBSlJGWg>? NVPsdI1KRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO3N|MyQDhpPkKzO|M{OTh6PD;hQi=>
MCF-7L  NFyxPIJHfW6ldHnvckBCe3OjeR?= NEHU[noyODBibl5CpC=> MX6xNEBucW5xMkSgbE81QCCq NVnuUolDemW|dXz0d{BqdiCHR1\SMEBJTVJ{IHHu[EBJTVJ|IIDoc5NxcG:{eXzheIlwdiCjdDDwdo9td26pZXSg[Zhxd3O3cnW= NFjTWnU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{[4OlQyPid-MkO2PFY1OTZ:L3G+
MCF-7L  NIm3fWdHfW6ldHnvckBCe3OjeR?= MlTPNVAxKG6PwrC= M4juXVQ5KGh? Mo[4bY5lfWOnczD1dJJm\3WuYYTpc44hd2ZibWLORUBw\iCHR1\SJIxq\2GwZDDIRk1GT0Z? M4XKSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|Nki2OFE3Lz5{M{[4OlQyPjxxYU6=
MCF-7L MXnGeY5kfGmxbjDBd5NigQ>? NEH3cI8yODBibl5CpC=> NF\zfm41QCCq M3PUTYlv\HWlZYOgSWdHWiCoYX3pcJkhdWWvYnXyJIFkfGm4YYTpc44hemWzdXny[YQhTVJ? NF;GdYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{[4OlQyPid-MkO2PFY1OTZ:L3G+
C4-12  MXnGeY5kfGmxbjDBd5NigQ>? MXexNFAhdk4EoB?= NXTK[HVSPDhiaB?= NWT3WJpMcW6mdXPld{BGT0[UIH\hcYltgSCvZX3i[ZIh[WO2aY\heIlwdiC{ZYH1bZJm\CCHUh?= MoXBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN4OE[0NVYoRjJ|Nki2OFE3RC:jPh?=
MCF-7L NUj5dHY5TnWwY4Tpc44hSXO|YYm= M2jP[FExOCCwTdMg MYOyOEBp Mnv5bY5lfWOnczDFS2ZTKHCqb4PwbI9zgWyjdHnvckBz\XG3aYLl[EBJSi2HR1[g[pVv[3Srb36= M3HyUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|Nki2OFE3Lz5{M{[4OlQyPjxxYU6=
MMQ  MULGeY5kfGmxbjDBd5NigQ>? NVHBcI1sOC14MkWgcm0> MVy3NkBp M1fOToRwf25vcnXneYxifGW|IITo[UBmgHC{ZYPzbY9vKG:oIHXzeJJw\2WwIILlZ4VxfG:{Ld8xJEhGWs7zKR?= M2n1UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NUKzN|U4Lz5{M{WyN|M2PzxxYU6=
H1975  Mof1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlHnNE4{OTJ3LUGwJO69VQ>? NX3GWmw3PiCm M1q4S4lvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz MkHRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|OUm5OVcoRjJ|M{m5PVU4RC:jPh?=
H1975  NXvXXm1ySXCxcITvd4l{KEG|c3H5 MWKyNFAhdk1? NYfmcVFNPzJiaB?= MoL0[Y5p[W6lZYOg[ZJtd3SrbnniJIlv\HWlZXSgZZBweHSxc3nz MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzN7OUm1O{c,OjN|OUm5OVc9N2F-
MCF-7  NHjkPIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXToeoFzOTBxMUCwM|ExODBibl2= M2ntUlIwPC94IHS= NWq3W4p2TE2VTx?= NWT2XGNWcW6qaXLpeJMh[2WubDDndo94fGhiaX6gZo91cCCmb4PlMUBidmRidHnt[U0h\GWyZX7k[Y51KG2jbn7ldi=> M17UUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{GzOVA3Lz5{M{OxN|UxPjxxYU6=
MCF-7  MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUmxNFAhdk1? Ml3mOEBl MnGzSG1UVw>? NGDLSoVqdmS3Y3XzJIEhcGmpaHXyJJBzd3CxcoTpc44hd2ZiY3XscJMhcW5idHjlJGcyKHCqYYPlxsA> NULSboM5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNVM2ODZpPkKzN|E{PTB4PD;hQi=>
MLO-Y4  NEfv[VBHfW6ldHnvckBCe3OjeR?= NIDnTHcyyqEQvF2= MXqxJIg> NYnTZmpRcW6qaXLpeJMhTTJvaX7keYNm\CCFeESzJIV5eHKnc4Ppc44> MljWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN{NEewOVcoRjJ|MkS3NFU4RC:jPh?=
MCF-7 NYjtOGxvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4DyU|ExOCCwTR?= MVW0PEBp Mlz5ZYJzd2ejdHXzJJRp\SCycn;sbYZmemG2aY\lJIVn\mWldDDv[kBud2SncnH0[UBvcXS{b4PheIl3\SC|dILld5M> NHrCU4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{KxOlc1PCd-MkOyNVY4PDR:L3G+
TG1-1  MoH0SpVv[3Srb36gRZN{[Xl? Mkn4NeKh|ryP MoPQNlQhcA>? NWjIeGpD[WK{b3fheIV{KEV{wrDpcoR2[2WmIHHjZ5VufWyjdHnvckBw\iCKSV[tNe6y NFTrU|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{C4PFYxPyd-MkOwPFg3ODd:L3G+
TG1-1  NHHXfYZHfW6ldHnvckBCe3OjeR?= NVvTTJR5OcLizszN NIHYOFQzPCCq MlvGZYJzd2ejdHXzJGUzyqCrbnT1Z4VlKGGlY4XteYxifGmxbjDv[kBRUTON NWnOd|hSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOwPFg3ODdpPkKzNFg5PjB5PD;hQi=>
MCF7 M1P5OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NInkWmIyODBibl2= M3PxbFQ5KGh? MXHs[YFleyC2bzDhJJNqdWmuYYKgcI9{eyCrbjDzeZJ3cX[jbDDhd{B4cXSqIHTvfI9zfWKrY3nuJIFtd26n MlXXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyN{eyOFkoRjJ|MEe3NlQ6RC:jPh?=
MCF7 MmOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nRe|ExOCCwTR?= NXH6WJp1PDhiaB?= NGjZNI9mdmijbnPld{BvfXSuaX6tcYVlcWG2ZXSgZ4VtdCCmZXH0bC=> M4f6SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEe3NlQ6Lz5{M{C3O|I1QTxxYU6=
MCF-7  MnHRSpVv[3Srb36gRZN{[Xl? NUjIZYhRPiCq NYDiSmxwTE2VTx?= M4LVSYF1fGWwdXH0[ZMhfGinIH\seYRqd3ixbnnsMUBweiCoZX7o[ZhidWmmLXnu[JVk\WRiaX7jdoVie2ViaX6gcYlTNTJzIHX4dJJme3Orb36= Ml\0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyNUKwN|YoRjJ|MEWyNFM3RC:jPh?=
MCF-7 M4\iS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnnDNVAxKG6PL{Gg{txO NHP6UVg2KGR? M4PFOIlvcGmkaYTzJJRp\SC|dHnteYxifGmxbjDv[kAyP87{LXXzeJJi\GmxbB?= MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl6Mke2OUc,OjJ7OEK3OlU9N2F-
MCF-7 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2DxS|ExOCCwTR?= MXi1JIQ> MVXpcohq[mm2czD0bIUhe3SrbYXsZZRqd25ib3[g[pV{[XKrZXzpckBJ NHrZRYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mkm4Nlc3PSd-MkK5PFI4PjV:L3G+
1471.1 MkS1SpVv[3Srb36gRZN{[Xl? NHnvb2QyODBibl2= MYmxJIg> M3nhcGV1V0kEoB?= M{[xOZRic2W|IH;uJIEheHWwY4TheIUhe3SjaX7pcocheGG2dHXyci=> MlHHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ6NkmxNFYoRjJ{OE[5NVA3RC:jPh?=
MCF-7 MVjGeY5kfGmxbjDBd5NigQ>? M4TGXVExOCCwTR?= NITOenUyKGh? M3[yN2V1V0kEoB?= MnvxeIFs\XNib36gZUBxfW6ldHH0[UB{fGGrbnnu[{Bx[XS2ZYLu NHnsT3Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki2PVExPid-MkK4OlkyODZ:L3G+
HeLa NVmyW4VtTnWwY4Tpc44hSXO|YYm= NInh[3kyODBibl2= NFu5OmwyKGh? NGLGNW5GfE:KwrC= NY\hV4ZyfGGtZYOgc44h[SCydX7jeIF1\SC|dHHpcolv\yCyYYT0[ZJv MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh4OUGwOkc,OjJ6NkmxNFY9N2F-
COS-7  NGDQSVZHfW6ldHnvckBCe3OjeR?= NFvvVWYyODBibl2= NFjhcokyKGh? M37hSmV1V0kEoB?= MlrheIFs\XNib36gZUBxfW6ldHH0[UB{fGGrbnnu[{Bx[XS2ZYLu NGizWYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mki2PVExPid-MkK4OlkyODZ:L3G+
BG1L-OHTLT  NGLCfmlHfW6ldHnvckBCe3OjeR?= NIHhZXkyOMLibl2= NH76Z3ozPMLiaNMg M3zYUIlvcGmkaYTzJGVT|rFiZYjwdoV{e2mxbh?= NYTyfVhCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK2OVI2PThpPkKyOlUzPTV6PD;hQi=>
BG1L-ICILT NETZR|RHfW6ldHnvckBCe3OjeR?= MWexNOKhdk1? NXXzNolWOjUEoHlCpC=> MVXpcohq[mm2czDFVu6yKGW6cILld5Nqd25? NFnN[5o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[1NlU2QCd-MkK2OVI2PTh:L3G+
PC-9 NIjXeYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV2wMlAxOy1|MDFOwG0> M3LKOFQ5KGh? M1XvOYlvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV4ME[zOEc,OjJ3NkC2N|Q9N2F-
H1650 M{K2Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXywMlAxOy1|MDFOwG0> MlH1OFghcA>? MoS3bY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> MlLUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ3NkC2N|QoRjJ{NU[wOlM1RC:jPh?=
H1975 NFnXeZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mnr4NE4xODNvM{Cg{txO NHHJ[3U1QCCq M1PLc4lvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\S2mZYDlcoRmdnRibXHucoVz NYroNYQ4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OlA3OzRpPkKyOVYxPjN2PD;hQi=>
H1975 MXrGeY5kfGmxbjDBd5NigQ>? Mn3wN:Kh|ryP MWGzJIg> Mo\vZYJzd2ejdHXzJJRp\SCyaH;zdIhwNUWJRmKgbY5lfWO2aX;uJIJ6KGW|dILv[4Vv NGDF[3o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkW2NFY{PCd-MkK1OlA3OzR:L3G+
H1975 NIrtZlVHfW6ldHnvckBCe3OjeR?= NX;GV4xNO8LizszN Mnr1O{Bl M2TBXYlv\HWlZYOgSWdHWiCneIDy[ZN{cW:w NXiycpVpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OlA3OzRpPkKyOVYxPjN2PD;hQi=>
HTR-8 Mn\SSpVv[3Srb36gRZN{[Xl? MWOxxsDPxE1? NELoc2cyNTR6IHi= MUjkc5dvNXKnZ4XsZZRmeyC2aHWg[ZhxemW|c3nvckBw\iCLR1\CVFchdVKQQR?= NEGxZm09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkO4N|EyOSd-MkKzPFMyOTF:L3G+
JEG-3 NELVXldHfW6ldHnvckBCe3OjeR?= MoKxNeKh|ryP NXrWbmhnOS12ODDo MVrkc5dvNXKnZ4XsZZRmeyC2aHWg[ZhxemW|c3nvckBw\iCLR1\CVFchdVKQQR?= NX7tZ5h1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKzPFMyOTFpPkKyN|g{OTFzPD;hQi=>
Huh7 NGe3UYVHfW6ldHnvckBCe3OjeR?= MmDsOVDDqM7:TR?= MYC0PEBp MmnwbY5pcWKrdIOg[4VvcXO2ZXnuMY1m\GmjdHXkJHBQVjFidILhcpNi[3SrdnH0bY9v MoX4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ|MESyPVYoRjJ{M{C0Nlk3RC:jPh?=
201T NX\2NVdzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{f2TVUh|ryP M2CyVlczKGh? M4r2SolvcGmkaYTzJINmdGxiZ4Lve5RpKHOrZ37p[olk[W62bImgZ49u[mmwZXSge4l1cCC4YX7k[ZRidmmk NFy4SXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK1PFQ4Pid-MkKyOVg1PzZ:L3G+
A549  NEDodWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NInB[mM2KM7:TR?= M2PZN|czKGh? M{XLWolvcGmkaYTzJINmdGxiZ4Lve5RpKHOrZ37p[olk[W62bImgZ49u[mmwZXSge4l1cCC4YX7k[ZRidmmk NXfqSHVQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyOVg1PzZpPkKyNlU5PDd4PD;hQi=>
MCF-7 Mn;oSpVv[3Srb36gRZN{[Xl? M1zaTlHDqM7:TR?= M4jrWFI1KGkEoB?= NFnEe2Vld3ewcnXneYxifGW|IFXSJIV5eHKnc4Ppc44hcW6mdXPl[EBjgSB2LV;IMXQhyqB? NVi1VI9TRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwOFk{OTZpPkKyNFQ6OzF4PD;hQi=>
HCC-1428 NVrhdHFGTnWwY4Tpc44hSXO|YYm= NXH0OYpDOcLizszN MWCyOEBpyqB? MXXkc5dvemWpdXzheIV{KEWUIHX4dJJme3Orb36gbY5lfWOnZDDifUA1NU:KLWSgxsA> MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB2OUOxOkc,OjJyNEmzNVY9N2F-
MDA-361 NUDhcnl4TnWwY4Tpc44hSXO|YYm= MWexxsDPxE1? MVGyOEBpyqB? Mmnn[I94dnKnZ4XsZZRmeyCHUjDlfJBz\XO|aX;uJIlv\HWlZXSgZpkhPC2RSD3UJOKh MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB2OUOxOkc,OjJyNEmzNVY9N2F-
ZR75-1 MWPGeY5kfGmxbjDBd5NigQ>? NEXCS|QyyqEQvF2= M2XNSFI1KGkEoB?= NV;nSINz\G:5boLl[5Vt[XSnczDFVkBmgHC{ZYPzbY9vKGmwZIXj[YQh[nliND3PTE1VKMLi NILrZZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkC0PVMyPid-MkKwOFk{OTZ:L3G+
MCF-7 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWLHdng2OcLizszN M2HTOFUuOTBiZB?= M{jrV5N2eHC{ZYPz[ZMhTTJvaX7keYNm\CCpcn;3eIghcW6qaXLpeIlwdg>? NUDQ[4VIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwOFk{OTZpPkKyNFQ6OzF4PD;hQi=>
HCC-1428 NEW5Sm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTjNeKh|ryP NWTpXo5LPS1zMDDk MmLCd5VxeHKnc4Pld{BGOi2rbnT1Z4VlKGe{b4f0bEBqdmirYnn0bY9v NGj4TnI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkC0PVMyPid-MkKwOFk{OTZ:L3G+
MDA-361 M{O4c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlG5NeKh|ryP MkjiOU0yOCCm NH6yc4Z{fXCycnXzd4V{KEV{LXnu[JVk\WRiZ4Lve5RpKGmwaHnibZRqd25? MkfaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJyNEmzNVYoRjJ{MES5N|E3RC:jPh?=
ZR75-1 M1z4PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3noUlHDqM7:TR?= MnvUOU0yOCCm Mo\kd5VxeHKnc4Pld{BGOi2rbnT1Z4VlKGe{b4f0bEBqdmirYnn0bY9v NFn3W209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkC0PVMyPid-MkKwOFk{OTZ:L3G+
MCF-7/AC-1 M3TnZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37Pb|AuOC5{IN88US=> NFPEUoo3KGR? NGXKbHVqdmirYnn0d{Bk\WyuIHfyc5d1cCCvb3Tld5RtgQ>? MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB2Mke5Nkc,OjJyNEK3PVI9N2F-
MCF7 NHTGUFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIG5WFgyOCEEtV2= NX\JZmpWPDhiaB?= MkKybY5lfWOnczDj[YxtKGmwaHnibZRqd25id3jpZ4gh[2GwIHLlJIVvcGGwY3XkJIJ6KG[rYoLvZoxie3S| MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB2MUi4O{c,OjJyNEG4PFc9N2F-
MMQ M4rLdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHyNE03OjVibl2= MYm3NkBp NHHPeZNxem:mdXPld{B{fGG2aYP0bYNidGy7IIPp[45q\mmlYX70JIlvcGmkaYTpc44hd2ZiY3XscEBxem:uaX\ldoF1cW:wwrC= NH72TpE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkCxOVExOSd-MkKwNVUyODF:L3G+
MMQ NHfuPG5HfW6ldHnvckBCe3OjeR?= NXL6cWNPOC14MkWgcm0> MVG3NkBp MlXGdJJw\HWlZYOgZUB{fGG2aYP0bYNidGy7IIPp[45q\mmlYX70MEBld3OnLXTldIVv\GWwdDDy[YR2[3Srb36gbY4hWFKOIIPlZ5JmfGmxbh?= M1HOe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEG1NVAyLz5{MkCxOVExOTxxYU6=
MCF7 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1;4flAuOSEQvF2= NXLHTZIzOjRvMUKwJIg> M3LEUolvcGmkaYTzJJRp\SCpcn;3eIghd2ZiTVPGO{1[Si1zwrC= MoD2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF6NkOyOVgoRjJzOE[zNlU5RC:jPh?=
HepG2 MofyRZBweHSxc3nzJGF{e2G7 M33z[|AvOcLizszN MoDuNlQhcA>? NFrGRlRi[m:uaYPo[ZMhfGinIHXzeJJw\2WwLXnu[JVk\WRidYCtdoVofWyjdHnvckBw\iCjcH;BTUBidmRiYYDvUS=> M2TkcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzOEG2NlM{Lz5{MUixOlI{OzxxYU6=
MCF7–iFR3 MoDKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4fWfVIxNTFyMDDuUS=> MlzzPVYhcA>? MYTlcohidmOnczDBVE1qdmS3Y3XkJINmdGxiZ4Lve5RpKGmwaHnibZRqd25? NULlTZNiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG3PVI5QDlpPkKxO|kzQDh7PD;hQi=>
MCF7S NI[zS2VHfW6ldHnvckBCe3OjeR?= MW[xxsDPxE1? MUe0PEBp NVXBNXFt\G:5boLl[5Vt[XSnczDveoVz[WyuIFXS{tEheHKxdHXpckBt\X[nbIO= MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTV|M{G5OUc,OjF3M{OxPVU9N2F-
MCF7 M3\VXmZ2dmO2aX;uJGF{e2G7 MV2xxsDPxE1? MkfvOFghcA>? M3m1[YRwf26{ZXf1cIF1\XNib4\ldoFtdCCHUt8xJJBzd3SnaX6gcIV3\Wy| NHPwPJo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUWzN|E6PSd-MkG1N|MyQTV:L3G+
MCF7S MoThSpVv[3Srb36gRZN{[Xl? MUGxxsDPxE1? M2n1ZVch\A>? MkPSZZR1\W63YYTld{B1fW2xcoPwbIVz\SCob4LtZZRqd25iYX7kJJBzd2yrZnXyZZRqd25? NEm5[pI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUWzN|E6PSd-MkG1N|MyQTV:L3G+
MCF7S NXu0dW45T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVqwMlUwOSEQvF2= NHjYTWE4KGR? NXfTVYpzTE2VTx?= MoOy[IVkemWjc3XzJINmdGxiZYjwZY5{cW:w MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTV|M{G5OUc,OjF3M{OxPVU9N2F-
T47D  MlHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVO0JI5O M2fhdlQxKGh? NIHHS2l{fXCycnXzd4V{KGOnbHyg[5Jwf3SqIH3v[IVz[XSnbIm= M4XqSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEiwN|kyLz5{MUS4NFM6OTxxYU6=
BT474  M4nMdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVu0JI5O M37ne|QxKGh? NV\nW2l4e3WycILld5NmeyClZXzsJIdzd3e2aDDtc4RmemG2ZXz5 MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR6MEO5NUc,OjF2OECzPVE9N2F-
T47D  NGj0T2ZHfW6ldHnvckBCe3OjeR?= Moe5NVAhdk1? NFHMemc1OCCq NF;CNJRld3ewcnXneYxifGW|IFXS{tEheHKxdHXpci=> M4WwWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNEiwN|kyLz5{MUS4NFM6OTxxYU6=
BT474  NGXDPG1HfW6ldHnvckBCe3OjeR?= M4C1OlExKG6P NUPwd3puPDBiaB?= NEm2VVlld3ewcnXneYxifGW|IFXS{tEheHKxdHXpci=> NEDiXYE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS4NFM6OSd-MkG0PFA{QTF:L3G+
MCF7 MULGeY5kfGmxbjDBd5NigQ>? Mn3RNVAxKG6P Mke1O{Bl NIL3[mNz\WS3Y3XzJGVT|rFiZYjwdoV{e2mxbjDzbYdvcW[rY3HueIx6 NU\xe5ViRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVYxQTRpPkKxN|k3ODl2PD;hQi=>
T47D  MXzGeY5kfGmxbjDBd5NigQ>? M1v2SlExOCCwTR?= NWrocotUPyCm M4DBZ5Jm\HWlZYOgSXLPuSCneIDy[ZN{cW:wIIPp[45q\mmlYX70cJk> M1SxfFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{m2NFk1Lz5{MUO5OlA6PDxxYU6=
BT474  MXzGeY5kfGmxbjDBd5NigQ>? M3rqN|ExOCCwTR?= MnzJO{Bl MkXFdoVlfWOnczDFVu6yKGW6cILld5Nqd25ic3nncolncWOjboTsfS=> MmWyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF|OU[wPVQoRjJzM{m2NFk1RC:jPh?=
MDAMB361 MVjGeY5kfGmxbjDBd5NigQ>? NF;WT|QyODBibl2= Ml;0O{Bl NVLVPIdWemWmdXPld{BGWs7zIHX4dJJme3Orb36gd4lodmmoaXPhcpRtgQ>? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTN7NkC5OEc,OjF|OU[wPVQ9N2F-
MCF7 M1TYU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmXENE4xOS1zIN88US=> NH61TWE4KGR? MmrhdoVlfWOnczDj[YxtKGe{b4f0bEB{cWewaX\pZ4FvfGy7 M4T1eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzM{m2NFk1Lz5{MUO5OlA6PDxxYU6=
T47D  M17VUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnnzNE4xOS1zIN88US=> NYDLcWFYPyCm NF\xfFlz\WS3Y3XzJINmdGxiZ4Lve5RpKHOrZ37p[olk[W62bIm= NU\B[5VwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVYxQTRpPkKxN|k3ODl2PD;hQi=>
BT474  MnmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF7WRowxNjBzLUGg{txO NV3JVHE5PyCm NEnXcplz\WS3Y3XzJINmdGxiZ4Lve5RpKHOrZ37p[olk[W62bIm= NXXuSnc5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVYxQTRpPkKxN|k3ODl2PD;hQi=>
MDAMB361 NUDxVHh[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYDxb5NTOC5yMT2xJO69VQ>? NHqwRok4KGR? MnGydoVlfWOnczDj[YxtKGe{b4f0bEB{cWewaX\pZ4FvfGy7 NFixdmk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUO5OlA6PCd-MkGzPVYxQTR:L3G+
MCF7 NGLvPGJHfW6ldHnvckBCe3OjeR?= NFfGNGIyODBibl2= M3XvO|ch\A>? MmTIbY5lfWOnczDv[kBGemKEMzDhcoQhTXKkQkSgdoVk\XC2b4Kg[ZhxemW|c3nvckBidmRic3nncoFtdGmwZx?= NHX6S5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUO5OlA6PCd-MkGzPVYxQTR:L3G+
T47D  NFHHeIZHfW6ldHnvckBCe3OjeR?= M3TwN|ExOCCwTR?= NUj1eVVrPyCm M3G4XIlv\HWlZYOgc4YhTXKkQkOgZY5lKEW{YlK0JJJm[2WydH;yJIV5eHKnc4Ppc44h[W6mIIPp[45idGyrbne= NV7VRoNXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVYxQTRpPkKxN|k3ODl2PD;hQi=>
BT474  MYHGeY5kfGmxbjDBd5NigQ>? NIjaVo4yODBibl2= Mm\qO{Bl MmHobY5lfWOnczDv[kBGemKEMzDhcoQhTXKkQkSgdoVk\XC2b4Kg[ZhxemW|c3nvckBidmRic3nncoFtdGmwZx?= Mo\UQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF|OU[wPVQoRjJzM{m2NFk1RC:jPh?=
MDAMB361 NGTqOIxHfW6ldHnvckBCe3OjeR?= M3Pa[FExOCCwTR?= M1rXc|ch\A>? NIHudo5qdmS3Y3XzJI9nKEW{YlKzJIFv\CCHcnLCOEBz\WOncITvdkBmgHC{ZYPzbY9vKGGwZDDzbYdv[WyuaX7n MnTwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF|OU[wPVQoRjJzM{m2NFk1RC:jPh?=
MCF7 MXrGeY5kfGmxbjDBd5NigQ>? M37KcVExKG6P MmDhPVYhcA>? M4SzPYRwf26{ZXf1cIF1\XNiRWKg[ZhxemW|c3nvcuKh NETae5E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUO3PFM{Oyd-MkGzO|g{OzN:L3G+
MDA-MB-231 MV7GeY5kfGmxbjDBd5NigQ>? NX:zc4d3OTBibl2= M3:xOFk3KGh? NV\tNYo5\G:5boLl[5Vt[XSnczDFVkBmgHC{ZYPzbY9vyqB? NHKxWJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUO3PFM{Oyd-MkGzO|g{OzN:L3G+
SK-BR-3 MlG2SpVv[3Srb36gRZN{[Xl? MnXuNVAhdk1? NY\OSHZ5QTZiaB?= NFniZmlld3ewcnXneYxifGW|IFXSJIV5eHKnc4Ppc47DqA>? NF;TZ489[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUO3PFM{Oyd-MkGzO|g{OzN:L3G+
MCF-7 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFnMU4cyODBibl2= MlW5O|IwQTZiaB?= M2XUZ4NifXOnczDj[YxtKGO7Y3zlJIFzemW|dB?= NEXYSok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUK5PVg3Oid-MkGyPVk5PjJ:L3G+
MMQ M2\mO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYT1bmo1OC5yMEitOlI2KG6P NH7TcGQ4OiCq MoLhbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYn;0bEB1cW2nLTDhcoQh\G:|ZT3k[ZBmdmSnboSgcYFvdmW{ MnLmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB5MEC3OVUoRjJyN{CwO|U2RC:jPh?=
MMQ NFrlZ41HfW6ldHnvckBCe3OjeR?= MlTvNE4xODhvNkK1JI5O M4HPdFczKGh? NHrlUYxqdmirYnn0d{BRWkxic3XjdoV1cW:wIHnuJIEh\G:|ZT3k[ZBmdmSnboSgcYFvdmW{ NHy0PHc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEewNFc2PSd-MkC3NFA4PTV:L3G+
MMQ M3XZeWZ2dmO2aX;uJGF{e2G7 NVzRU4d6OC5yND22NlUhdk1? M321OlczKGh? NGG5T4RqdmirYnn0d{BGWs7zIHX4dJJme3Orb36= M3TzZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyN{CwO|U2Lz5{MEewNFc2PTxxYU6=
MMQ MofZSpVv[3Srb36gRZN{[Xl? NWrSdWtbOC5yND22NlUhdk1? NXzwcIxNPzJiaB?= NWHHc4dYfXC{ZXf1cIF1\XNiVFfG{tI{KGGwZDDUS2bPulKLSTDlfJBz\XO|aX;u NVj0TXJ1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkC3NFA4PTVpPkKwO|AxPzV3PD;hQi=>
MCF7 NUj2b|l2TnWwY4Tpc44h[XO|YYm= MlryOkBl[Xm| MWTJcoR2[3Srb36gc4YhTVKjbIDoZUBl\We{YXTheIlwdiCrbjDoeY1idiCPQ1[3JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiaX7zeYxqdi2vZXTpZZRm\CClZXzsJJBzd2yrZnXyZZRqd25iYX\0[ZIhPiCmYYnzJIJ6KEixZXPod5QhOzN{NUig[JlmNWKjc3XkJIF{e2G7LDDJR|UxKD1iMD6wNFAxPiEQvF2u M{DRXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6Mkm2N|k5Lz5{OEK5OlM6QDxxYU6=
MCF7 MlrqSpVv[3Srb36gZZN{[Xl? M3;nRWFvfGGpb37pd5Qh[WO2aY\peJkh[XRiRWLhcJBp[SC{ZXPldJRweiCrbjDoeY1idiCPQ1[3JINmdGy|LDDJR|UxKD1iMD6wNFAxPjNzIN88UU4> NFvBR449[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkSwO|AyOid-Mk[0NFcxOTJ:L3G+
MCF7 MofRSpVv[3Srb36gZZN{[Xl? M3v5Z|QhcHK| M{PBSGlv\HWldHnvckBw\iCHUnHsdIhiKGSnZ4Lh[IF1cW:wIHnuJIh2dWGwIF3DSlch[2WubIOgbY4heGinbn;sJJJm\CCocnXlJHJRVUlibXXkbZVuKGOxboThbY5qdmdiNTWgZ4hiemOxYXyg[IV5fHKjbj30doVifGWmIF\CV{BqdmO3YnH0[YQh\m:{IESgbJJ{KGK7IGPQNUBidmRiYX70bU1GWiC{YXLibZQhdW:wb3PvcI5idCCjboTpZo9lgSCkYYPl[EBqdi2lZXzsJHdme3Sncn6gZZN{[XluIFHjeIl3cXS7IE2gNE4xODBzIN88UU4> NEn6dok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEC4OlYzPid-M{CwPFY3OjZ:L3G+
MCF7 MVPGeY5kfGmxbjDhd5NigQ>? NFXQTZgzPCCqcoO= NF;SfG5Rem:2ZX;sfZNqeyC2YYLn[ZRqdmdiY3jpcYVz[SCjY4Tpeol1gSCrbjDoeY1idiCPQ1[3JINmdGy|IHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCHMzD1ZolyfWm2aX6gcIlo[XOnLX3l[IlifGWmIFXSZYxxcGFiZHXndoFl[XSrb36gZpkheHKxdHXhd49u\SCjZoTldkAzPCCqcoOgZpkhcW5vY3XscEBY\XO2ZYLuJIF{e2G7LDDJR|UxKD1iMD6wNFAyKM7:TT6= NUeyU45vRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CxNlgxPzFpPkOwNVI5ODdzPD;hQi=>
MCF7 NF\2e4xHfW6ldHnvckBie3OjeR?= MVrBcpRi\2:waYP0JIFkfGm4aYT5JIF1KHC{b3fld5Rmem:wZTDy[YNmeHSxcjDpckBpfW2jbjDNR2Yh[2WubIOgZZN{\XO|ZXSgZZMh\XO2cnHkbY9tNWmwZIXj[YQhemWlZYD0c5IhemW|cH;ud4UtKEmFNUCgQUAxNjByMEKwPFkh|ryPLh?= NInUdFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkSwO|AyOid-Mk[0NFcxOTJ:L3G+
MCF7 NXzufmNZTnWwY4Tpc44h[XO|YYm= M4P2RlI1KGi{cx?= NI\ST4FFd3ewcnXneYxifGmxbjDv[kBpfW2jbjDFVoFteGijIHnuJIh2dWGwIF3DSk04KGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDpck1k\WyuIGfld5Rmem5iaX3teY5w[XO|YYmgcYV1cG:mLDDJR|UxKD1iMD6wNFA{KM7:TT6= Mni0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh4NUezNlAoRjJ6NkW3N|IxRC:jPh?=
MCF7 NXP4XWR4TnWwY4Tpc44h[XO|YYm= MorSOEBpenN? M1nLWGlv\HWldHnvckBw\iCnc4Tyc4dmdiC{ZXPldJRwei2jbIDoZUBl\We{YXTheIlwdiCrbjDoeY1idiCPQ1[3JINmdGy|IHHmeIVzKDRiaILzJIJ6KGmwLXPlcIwhf2W|dHXyckBie3OjeTygSWM2OCB;IECuNFAxPCEQvF2u MnH2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6N{m0PFUoRjJ3OEe5OFg2RC:jPh?=
MCF7 NHLjV4tHfW6ldHnvckBie3OjeR?= NWXsdYRFPCCqcoO= M4Xod2Rm[3KnYYPlJIlvKGW|dILv[4VvKHKnY3XweI9zKGGucHjhJIxmfmWuIHnuJIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiNDDodpMh[nliaX6tZ4VtdCC5ZYP0[ZJvKGG|c3H5MEBGSzVyIE2gNE4xODB2IN88UU4> NYGweVU5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[0OlMyOzBpPkK2OFY{OTNyPD;hQi=>
MCF7 NEjaTppHfW6ldHnvckBie3OjeR?= MWTBcpRi\2:waYP0JIVn\mWldDDvckB1emGwc3PybZB1cW:wYXygZYN1cX[jdHnvckBqdiCPQ1[tO{Bk\WyuczDlfJBz\XO|aX7nJIV{fHKxZ3XuJJJm[2WydH;yJIFteGijLDDJR|UxKD1iMD6wNFA1PyEQvF2u NHvxVnc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zME[3N|A6QSd-MUC2O|MxQTl:L3G+
MCF7 NE\5coVHfW6ldHnvckBie3OjeR?= M{PhXWlvcGmkaYTpc44hd2ZiZYP0do9o\W5vaX7keYNm\CCycn;sbYZmemG2aX;uJIlvKGi3bXHuJG1ETi15IHLy[YF{fCClYX7j[ZIh[2WubIOsJGlEPTBiPTCwMlAxODR7IN88UU4> M{\Eb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzlzNUS5OlMoRjlzNUS5OlM9N2F-
MCF7 MXnGeY5kfGmxbjDhd5NigQ>? MY[yOEBpenN? NYLO[XA5SW62YXfvcol{fCCjY4Tpeol1gSCjdDDld5Rzd2enbjDy[YNmeHSxcjDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gNVdj\XSjLXXzeJJi\GmxbD3t[YRq[XSnZDD0doFve2O{aYD0bY9v[WxiYXP0bZZifGmxbjDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyIE2gNE4xODB4IN88UU4> M1X0[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEe5OFg2Lz5{NUi3PVQ5PTxxYU6=
MCF7 M2S0dGZ2dmO2aX;uJIF{e2G7 NVn5XHA1OThidH:gNlQhcHK| M1GxO2lv\HWldHnvckBw\iCHUnHsdIhiKGSnZ4Lh[IF1cW:wIHnuJIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiMUigeI8hOjRiaILzJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrczygTWM2OCB;IECuNFAyKM7:TT6= NHPyZ5A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEK5OlM6QCd-MkiyPVY{QTh:L3G+
MCF7 NYX4WlZLTnWwY4Tpc44h[XO|YYm= NF;nO4MyQCCqcoO= NGP2OWxKdmS3Y4Tpc44hd2ZiRWLhcJBp[SCmZXfyZYRifGmxbjDpckBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IEG4JIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZMtKEmFNUCgQUAxNjByMUKg{txONg>? MmXYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{OU[zPVgoRjJ6Mkm2N|k5RC:jPh?=
MCF7 NIDKXYdHfW6ldHnvckBie3OjeR?= M2rEe|E5KHSxIEK0JIhzew>? MU\JcoR2[3Srb36gc4Yhe2WuZXP0bZZmKGW|dILv[4VvKHKnY3XweI9zKGGucHjhJIRm\3KjZHH0bY9vKGmwIHj1cYFvKE2FRkegZ4VtdHNiYX\0[ZIhOThidH:gNlQhcHK|IHL5JIlvNWOnbHygW4V{fGW{bjDhcoFtgXOrczygTWM2OCB;IECuNFAyOiEQvF2u MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV4MkezO{c,Ojl3NkK3N|c9N2F-
MCF7 MVPGeY5kfGmxbjDhd5NigQ>? NF7qT2kzPCCqcoO= NGL3VlZCdnSjZ3;ubZN1KGGldHn2bZR6KGG2IFXSZYxxcGFiaX6gbJVu[W5iTVPGO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHXzeJJw\2WwLXnu[JVk\WRidILhcpNkemmydHnvckBxemWrbnP1ZoF1\WRib4\ldo5q\2i2IH\vcIxwf2WmIHL5JIV{fHKxZ3XuJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEK0JIhzeyCkeTDkeYFtKGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OCB;IECuNFA{PCEQvF2u MnjhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{OU[zPVgoRjJ6Mkm2N|k5RC:jPh?=
MCF7 M1;zZWZ2dmO2aX;uJIF{e2G7 M3LMSlI1KGi{cx?= MVrJcoR2[3Srb36gc4Yhe2WuZXP0bZZmKGW|dILv[4VvKHKnY3XweI9zKGGucHjhJIRm\3KjZHH0bY9vKGmwIHj1cYFvKE2FRkegZ4VtdHNiaHHyZo9zcW6pIGTLMWVTTS2OdXOgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKGmwIHXzeJJi\GmxbD3pcoR2[2WmIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCjZoTldkAzPCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDJR|UxKD1iMD6wNFM1KM7:TT6= NH7MeYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUW2Nlc{Pyd-Mkm1OlI4Ozd:L3G+
COS7 MnTySpVv[3Srb36gZZN{[Xl? MkPvRY51[WexbnnzeEBi[3Srdnn0fUBifCCnc4Tyc4dmdiC{ZXPldJRweiCkZYThJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS0:VNzDj[YxteyClbz30doFve2[nY4Tl[EB4cXSqIFfhcFQuVEKGIHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiSVO1NEA:KDBwMECzPEDPxE1w MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh4M{C4N{c,OTl6NkOwPFM9N2F-
MCF7 Ml65SpVv[3Srb36gZZN{[Xl? M4PQdVI1KGi{cx?= M3rFU2lv\HWldHnvckBw\iC|ZXzlZ5RqfmViZYP0do9o\W5icnXj[ZB1d3JiYXzwbIEh\GWpcnHkZZRqd25iaX6gbJVu[W5iTVPGO{Bk\WyuczDoZZJjd3KrbnegWGsuTVKHLVz1Z{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6g[ZN1emGmaX;sMYlv\HWlZXSgS3JGSjFibWLORUBmgHC{ZYPzbY9vKGGodHXyJFI1KGi{czDifUBV[XGPYX6gZZN{[XluIFnDOVAhRSByLkCwN|gh|ryPLh?= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTV4MkezO{c,Ojl3NkK3N|c9N2F-
COS7 NGPxeWpHfW6ldHnvckBie3OjeR?= NGTzfZdCdnSjZ3;ubZN1KGGldHn2bZR6KGG2IHXzeJJw\2WwIILlZ4VxfG:{IHHsdIhiKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TO{Bk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGdidDRvTFLEJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygTWM2OCB;IECuNFA1KM7:TT6= MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh4M{C4N{c,OTl6NkOwPFM9N2F-
Rosetta 2 DE3 competent cell MX\GeY5kfGmxbjDhd5NigQ>? M4HLWlEhcHJ? MY\EbZNxdGGlZX3lcpQhd2ZiW{PIYU1me3S{YXTpc4wh\nKxbTDy[YNwdWKrbnHueEBpfW2jbjDOMZRmem2rbnHsJGhqey22YXfn[YQhTVKjbIDoZUBNSkRiaHHyZo9zcW6pIFOzPFFUN0N2MUfTM2M2OzCVIH31eIFvfCCneIDy[ZN{\WRiaX6gVo9{\XS2YTCyJGRGOyClb33w[ZRmdnRiY3XscJMh[W[2ZYKgNUBpeiCkeTDTVGEh[mmwZHnu[{Bie3OjeTygTWM2OCB;IECuNFA5PCEQvF2u NF\GRpQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEK5OlM6QCd-MkiyPVY{QTh:L3G+
HepG2 M3jUT2Z2dmO2aX;uJIF{e2G7 NGL3[YsyPiCqcoO= MXLB[49vcXO2IHHjeIl3cXS7IHH0JHBZWiBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiQ2nQN2E1KHS{YX7zZYN1cX[jdHnvckBi\nSncjCxOkBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOS57NTFOwG0v MoTxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN4OEi1OVkoRjJ|Nki4OVU6RC:jPh?=
MCF7 NVzUb|FtTnWwY4Tpc44h[XO|YYm= MYGxNEB2VQ>? MWOzJIRigXN? NFi2SFJKdmirYnn0bY9vKG:oIHnuZ5Jm[XOnIHnuJJBzd2yrZnXyZZRqd25ib3[g[ZN1em:pZX6gdoVk\XC2b4Kg[ZhxemW|c3nu[{BOS0Z5IHPlcIx{KGG2IEGwJJVOKGGodHXyJFMh\GG7cx?= NH3OepY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{K3OVMyPSd-MUeyO|U{OTV:L3G+
MVLN MYfGeY5kfGmxbjDhd5NigQ>? M4XlPVI1KGi{cx?= NIXzUHFC[3Srdnn0fUBifCCHUjDhd5Nme3OnZDDhd{B{fXCycnXzd4lwdiCxZjDld5Rzd2enbjDy[ZNxd26|ZTDlcIVu\W62LXTybZZmdiCpZX7lJJRz[W6|YXP0bZZifGmxbjDpckBOXkyQIHPlcIx{KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? NHXzRZA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{K3OVMyPSd-MUeyO|U{OTV:L3G+
T47D MYrGeY5kfGmxbjDhd5NigQ>? MmfLOUB2VQ>? M3Xk[2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gSXJidHCqYTDpckBVPDeGIHPlcIx{KGG|c3Xzd4VlKGG|IHXubIFv[2WvZX70JI9nKEGSMT3kdol3\W5idILhcpNi[3SrdnH0bY9vKGG2IEWgeW0h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDhd5NigSC{ZXzheIl3\SC2bzDEUXNQ MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzN|N{G4N{c,OTd|M{exPFM9N2F-
MCF7 MkLtSpVv[3Srb36gZZN{[Xl? NUXZSlJbPDVibXnudy=> MoHsRolv\GmwZzDh[oZqdmm2eTD0c{Bme3S{b3flckBz\WOncITvdkBidHCqYTDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gX|NJZUV{IHHjZ5VufWyjdHnvckBi\nSncjC0OUBucW6|IHL5JJdpd2ynIHPlcIwh[2:vcHX0bZRqd25iYnnu[Ilv\yCjc4PhfS=> NXXBRldJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmxN|M4PzdpPkG5NVM{Pzd5PD;hQi=>
MCF7 MkDPSpVv[3Srb36gZZN{[Xl? MYWyOEBpenN? NUSxbIdRTG:5bjDy[Yd2dGG2aX;uJI9nKGW|dILv[4VvKHKnY3XweI9zKGGucHjhJIV5eHKnc4Ppc44hcW5iaIXtZY4hVUOINzDj[YxteyCjZoTldkAzPCCqcoOgZpkhX2W|dHXyckBjdG:2IHHuZYx6e2m| MojaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzM{O3O|coRjF7MUOzO|c4RC:jPh?=
MCF7 MlPHSpVv[3Srb36gZZN{[Xl? MU[xNFAhdk1? MmHZNlQhcHK| MYnEc5dvKHKnZ4XsZZRqd25ib3[g[ZN1em:pZX6gdoVk\XC2b4KgZYxxcGFiZYjwdoV{e2mxbjDpckBpfW2jbjDNR2Y4KGOnbHzzJIF1KDFyMDDuUUBi\nSncjCyOEBpenNiYomgbY1ufW6xZnz1c5Jme2OnbnPlJJN1[WmwaX7n NHzOcVM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUGzN|c4Pyd-MUmxN|M4Pzd:L3G+
MCF7:D5L MXHGeY5kfGmxbjDhd5NigQ>? NWPkbZQ4OSC3TR?= NHzDb21CdnSjZ3;ubZN1KGGldHn2bZR6KGG2IFXSZYxxcGFiaX6gbJVu[W5iTVPGO|pFPUxiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBGWkVvZHXw[Y5l\W62IHz1Z4ln\XKjc3Wg[ZhxemW|c3nvckBifCBzIIXN M17oZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OES1N|g3Lz5zOUi0OVM5PjxxYU6=
HEK293 MnrGSpVv[3Srb36gZZN{[Xl? MU[xJJVO MVHBcpRi\2:waYP0JIFkfGm4aYT5JIF1KEWUYnX0ZUBqdiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDFVmUu\GWyZX7k[Y51KGy3Y3nm[ZJie2ViZYjwdoV{e2mxbjDheEAyKHWP M{jZZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OES1N|g3Lz5zOUi0OVM5PjxxYU6=
Ishikawa NHHQT29HfW6ldHnvckBie3OjeR?= MVuxJJVO NYPJV|BkSW62YXfvcol{fCCjY4Tpeol1gSCjdDDld5Rzd2enbjDy[YNmeHSxcjDpckBpfW2jbjDJd4hqc2G5YTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEWURT3k[ZBmdmSnboSgZYxs[WyrbnWgdIhwe3CqYYThd4UhdGW4ZXzzJIF1KDFidV2= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh2NUO4Okc,OTl6NEWzPFY9N2F-
HeLa MoPhSpVv[3Srb36gZZN{[Xl? Mn;RNUB2VQ>? M1rPXFQ5KGi{cx?= NYnqVJNrSW62YXfvcol{fCCjY4Tpeol1gSCjdDDoeY1idiCHUnHsdIhiKGW6cILld5Nm\CCrbjDoeY1idiCKZVzhJINmdGy|IHPv[ZhxemW|c3nu[{BGWkVvRUHiMWx2[yCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGW|dILh[IlwdC2rbnT1Z4VlKHS{YX7zZ5JqeHSrb37hcEBi[3SrdnH0bY9vKGG2IEGgeW0h[W[2ZYKgOFghcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODZ{MUS5Nkc,OjB4MkG0PVI9N2F-
HeLa MnLLSpVv[3Srb36gZZN{[Xl? MXuxNFAhdk1? NXn5NHVXOjBidH:gNlQhcHK| MVvBcpRi\2:waYP0JIFkfGm4aYT5JIF1KEyERDDv[kBGWmGucHjhJJJm[2WydH;yJIlvKGi3bXHuJGhmVGFiY3XscJMh[XO|ZYPz[YQh[XNiYnzvZ4ti\GVib3[gV3JENTFiYnnu[Ilv\yC2bzDy[YNmeHSxcjDheEAyODBibl2gZYZ1\XJiMkCgeI8hOjRiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeR?= NFLvVGU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{S0PFM1Pid-MkO0OFg{PDZ:L3G+
MCF7 MlvhSpVv[3Srb36gZZN{[Xl? MUmxNEBvVQ>? MoP1O|IhcHK| MnX3TY5pcWKrdHnvckBw\iBzN3LleIEu\XO2cnHkbY9tNWmwZIXj[YQhcW5iRWLhcJBp[SCyb4PpeIl3\SCqdX3hckBOS0Z5IHPlcIx{KHC{b3zp[oVz[XSrb36gZZN{\XO|ZXSgZZMhYzOKXT30bJlucWSrbnWgbY5kd3Kyb4LheIlwdiCjdDCxNEBvVSCjZoTldkA4OiCqcoOgZpkhdGmzdXnkJJNkcW62aXzsZZRqd25iY3;1cpRqdmd? M13aR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUC4OlUzLz5{NEmwPFY2OjxxYU6=
MCF7 Mnv5SpVv[3Srb36gZZN{[Xl? MVmxJJVO MUOyNEBpenN? NUnP[ZM2UW6mdXP0bY9vKG:oIHXzeJJw\2WwIILlZ4VxfG:{LXHsdIhiKGSnZ4Lh[IF1cW:wIHnuJIh2dWGwIF3DSlch[2WubIOgZZQhOSC3TTDh[pRmeiB{MDDodpMh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nz NHTpO4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUi3PVQ5PSd-MkW4O|k1QDV:L3G+
MCF7 M17hWGZ2dmO2aX;uJIF{e2G7 MXuwMlAyKHSxIEOwNEBvVQ>? NW\IUoFoPDhiaILz NVrUVZlWTGWpcnHkZZRqd25iYXP0bZZqfHlib3[gSXJidHCqYTDy[YNmeHSxcjDpckBpfW2jbjDNR2Y4KGOnbHzzJIF1KDBwMEGgeI8hOzByIH7NJIFnfGW{IES4JIhzeyCkeTDX[ZN1\XKwIHLsc5Qh[W6jbInzbZM> MonyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ2MEewNVIoRjJ4NEC3NFEzRC:jPh?=
Neuro2a NWLyPVZlTnWwY4Tpc44h[XO|YYm= M2XI[|EhfU1? NYS3dooyUW6qaXLpeIlwdiCxZjDEVlI1KGmwIFToZ5I4NWSnZnnjbYVvfCCvb4Xz[UBP\XW{b{LhJINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKDdvRFjDJIxmfmWuczDheEAyKHWPIHL5JGxENU2VL1fDMW1UKGGwYXz5d4l{ MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjd6OU[1O{c,OjZ5OEm2OVc9N2F-
MCF-7 MmTESpVv[3Srb36gZZN{[Xl? MVezJI5ONCB|MDDuUUwhOzByIH7NMEA{KHWP NILufY4zPCCqcoO= NEnuUWhFd3ewcnXneYxifGmxbjDv[kBGWmGucHjhJIlvKGi3bXHuJG1ETi15IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDv[kBme3S{YXTpc4wucW6mdXPl[EBIWkWEMTDtVm5CKGyndnXsd{BifCB|IIigNVAoNTliTTygN{B5KDFyJz24JG0tKDNieDCxNEcuPyCPLDCzJJghOTBpLU[gUUBi\nSncjCyOEBpenNiYomgVnQuWEOUIH3leIhw\A>? NGS0[|Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OE[1O|MzOCd-Mki2OVc{OjB:L3G+
MCF-7 NFLETXlHfW6ldHnvckBie3OjeR?= MnPUN{BvVSxiM{Cgcm0tKDNyMDDuUUwhOyC3TR?= MVeyOEBpenN? MWTEc5dvemWpdXzheIlwdiCxZjDFVoFteGijIHnuJIh2dWGwIF3DSk04KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCxZjDld5Rz[WSrb3ytbY5lfWOnZDDQ[3IhdVKQQTDs[ZZmdHNiYYSgN{B5KDFyJz25JG0tKDNieDCxNEcuQCCPLDCzJJghOTBpLUegUUwhOyC6IEGwK{03KE1iYX\0[ZIhOjRiaILzJIJ6KFKWLWDDVkBu\XSqb3S= NXHsSYFsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki2OVc{OjBpPkK4OlU4OzJyPD;hQi=>
MCF-7 NX;qSXptTnWwY4Tpc44h[XO|YYm= NUPFVVRHOyCwTTygN|Ahdk1uIEOwNEBvVSxiMzD1US=> MVyyOEBpenN? Mm[1SI94dnKnZ4XsZZRqd25ib3[gSXJidHCqYTDpckBpfW2jbjDNR2YuPyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25ib3[g[ZN1emGmaX;sMYlv\HWlZXSgdHMzKG2UTlGgcIV3\Wy|IHH0JFMhgCBzMDetPUBONCB|IIigNVAoNThiTTygN{B5KDFyJz23JG0tKDNieDCxNEcuPiCPIHHmeIVzKDJ2IHjyd{BjgSCUVD3QR3IhdWW2aH;k NV;rSZhbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki2OVc{OjBpPkK4OlU4OzJyPD;hQi=>
MCF7 NH;HZYFHfW6ldHnvckBie3OjeR?= NIfMPWMyOCC3TR?= M1PhcFI1KGi{cx?= MXHJcoR2[3Srb36gc4Yhe2WuZXP0bZZmKGW|dILv[4VvKHKnY3XweI9zKGGucHjhJIRm\3KjZHH0bY9vKGmwIHj1cYFvKE2FRkegZ4VtdHNiYYSgNVAhfU1iYX\0[ZIhOjRiaILzJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrcx?= M3PEe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NU[yO|M4Lz5{OUW2Nlc{PzxxYU6=
Assay
Methods Test Index PMID
Western blot MDM2 / ER ; p-ErbB3 Y1289 / ErbB3 / p-ErbB4 Y1056 / ErbB4 / p-AKT / AKT / p-ERK / ERK ; ErbB3 ; ERα 24747123 21396094 23999432 19815064
Immunofluorescence IGF-1R / Erα ; Snail / E-cadherin 19815064 23936773
Growth inhibition assay Cell viability 29787591
In vivo Fulvestrant is devoid of uterotropic activity, and when co-administered with estradiol, it effectively blocks the uterotropic action of estradiol with ED50 of 0.06 mg/kg/day s.c. in immature female rats. A single s.c. injection of 5 mg of Fulvestrant suspension blocks completely the growth of MCF-7 xenografts. The growth of transplants of the BrlO human breast tumor is also suppressed effectively by 10 μM Fulvestrant. [1] Fulvestrant (10 mg/rat, s.c.) reduces the androgen receptor expression, ERK1/2 phosphorylation and cell proliferation in the rat ventral prostate. [7] Fulvestrant also displays anti-angiogenesis in the chick egg chorioallantoic membrane. [8]

Protocol (from reference)

Cell Research:[1]
  • Cell lines: MCF-7 breast cancer cells
  • Concentrations: 2.9 nM
  • Incubation Time: 5 days
  • Method: MCF-7 cells are cultured in multiwell plates (24-well, seeding density 4 × 104) in minimal essential medium containing phenol red, insulin (10 μg/mL), and 5% charcoal-stripped fetal calf serum without additional estradiol. Fulvestrant and/or estradiol are added in fresh medium 2 days after seeding. Cultures are maintained for 5 days with one further medium change and growth is assessed by measurement of total cell protein at the beginning and end of treatment and compared with that of controls treated with ethanol (0.1%) alone.
  • (Only for Reference)
Animal Research:[6]
  • Animal Models: The human breast cancer xenografts MCF-7 in nude mice
  • Dosages: 5 mg/mouse
  • Administration: s.c. injection
  • (Only for Reference)

Solubility (25°C)

In vitro

DMSO 100 mg/mL
(164.8 mM)
Water Insoluble
Ethanol '''100 mg/mL

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
2% DMSO+30% PEG 300+2% Tween 80+ddH2O
For best results, use promptly after mixing.

0.4mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 606.77
Formula

C32H47F5O3S

CAS No. 129453-61-8
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05191004 Not yet recruiting Drug: NUV-422|Drug: Fulvestrant Advanced Breast Cancer|Metastatic Breast Cancer|Breast Cancer|Breast Carcinoma|Cancer of the Breast|Cancer of Breast|Malignant Tumor of Breast|Breast Tumor Nuvation Bio Inc. March 2022 Phase 1|Phase 2
NCT05082025 Not yet recruiting Drug: Copanlisib|Drug: fulvestrant Endometrial Cancer|Ovarian Cancer M.D. Anderson Cancer Center|Bayer February 28 2022 Phase 2
NCT05181033 Not yet recruiting Drug: Lenvatinib + Letrozole|Drug: Fulvestrant Breast Cancer National University Hospital Singapore|Eisai Co. Ltd. January 2022 Phase 2
NCT05135104 Not yet recruiting Drug: Palbociclib Metastatic Breast Cancer Asociatia Oncohelp - Centrul de Oncologie Oncohelp|MDX Research November 15 2021 --
NCT05022342 Recruiting Other: alpelisib plus fulvestrant Breast Cancer Novartis Pharmaceuticals|Novartis October 27 2021 --

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
Is there any information for the half-life of fulvestrant (Cat No.S1191)?

Answer:
S1191, is about 13.5 to 18.5 hours in vivo: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750771/. The half life of these compounds in cell culture might be different and we generally recommend replenishing with fresh drug every 24-48 hours.

Tags: buy Fulvestrant (ICI-182780) | Fulvestrant (ICI-182780) ic50 | Fulvestrant (ICI-182780) price | Fulvestrant (ICI-182780) cost | Fulvestrant (ICI-182780) solubility dmso | Fulvestrant (ICI-182780) purchase | Fulvestrant (ICI-182780) manufacturer | Fulvestrant (ICI-182780) research buy | Fulvestrant (ICI-182780) order | Fulvestrant (ICI-182780) mouse | Fulvestrant (ICI-182780) chemical structure | Fulvestrant (ICI-182780) mw | Fulvestrant (ICI-182780) molecular weight | Fulvestrant (ICI-182780) datasheet | Fulvestrant (ICI-182780) supplier | Fulvestrant (ICI-182780) in vitro | Fulvestrant (ICI-182780) cell line | Fulvestrant (ICI-182780) concentration | Fulvestrant (ICI-182780) nmr